|
시장보고서
상품코드
2032456
하대정맥 필터 시장 : 제품별, 소재별, 용도별, 최종 사용자별, 지역별(2026-2034년)Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034 |
||||||
세계의 하대정맥(IVC) 필터 시장 규모는 2025년에 8억 2,280만 달러에 이르렀습니다. 향후 IMARC Group은 2034년까지 시장 규모가 15억 380만 달러에 이르고, 2026-2034년 CAGR 6.72%를 나타낼 것으로 예측했습니다. 심부정맥혈전증(DVT) 및 폐색전증(PE)의 유병률 증가, 질환의 위험과 결과에 대한 소비자의 인식 증가, 최소침습적 수술에 대한 선호도 증가 등이 시장을 주도하는 주요 요인으로 작용하고 있습니다.
하대정맥(IVC) 필터는 하체에서 폐로 혈전이 이동하는 것을 방지하고 폐색전증의 위험을 줄이기 위해 고안된 의료기기입니다. 이것은 금속 또는 합성 재료로 제조된 작고 케이지 모양의 구조물입니다. 하체에서 산소가 없는 혈액을 심장으로 운반하는 하대정맥에 삽입됩니다. 혈전을 포획하고 폐에 도달하는 것을 방지하여 물리적 장벽 역할을 합니다.
현재 혈전 형성 위험이 높은 환자에서 IVC 필터의 채택이 확대되면서 시장 성장에 기여하고 있습니다. 이와 더불어, 의료 제공업체의 유리한 상환 정책을 배경으로 한 IVC 필터의 사용 증가는 시장 성장을 가속하고 있습니다. 또한, 정맥혈전색전증 발병 위험이 높은 고령층에서 IVC 필터의 채택이 확대되고 있는 점도 시장 성장을 견인하고 있습니다. 또한, 전 세계적으로 저침습 수술에 대한 선호도가 높아지면서 IVC 필터에 대한 수요 증가도 시장에 긍정적인 영향을 미치고 있습니다. 또한, 의료 인프라 개선에 따른 의료 솔루션 채택 확대도 시장 성장을 강화하고 있습니다.
하대정맥(IVC) 필터 시장 동향 및 촉진요인:
심부정맥혈전증(DVT) 및 폐색전증(PE)의 유병률 증가
세계적으로 심부정맥혈전증(DVT) 및 폐색전증(PE)의 유병률이 증가함에 따라 IVC 필터에 대한 수요가 증가하고 있습니다. 심부정맥혈전증은 보통 심부정맥(주로 다리)에 혈전이 형성되어 발생합니다. 또한, 이러한 혈전이 떨어져 나와 폐로 흘러 들어가면 폐색전증이라는 생명을 위협하는 질환을 유발할 수 있습니다. 좌식 생활, 비만, 부적절한 신체 활동 및 기타 생활 습관 관련 문제로 인해 DVT 및 PE에 직면하는 사람들이 증가하고 있습니다. 또한, 고령화 인구층에서 DVT 발병 위험이 증가하고 있습니다. 또한, 의료진은 PE 발생과 그에 따른 이환율 및 사망률을 줄이기 위해 고위험군 환자를 위한 예방책으로 IVC 필터를 점점 더 많이 채택하고 있습니다.
질병의 위험과 결과에 대한 소비자의 인식이 높아졌습니다.
의료진과 일반인들 사이에서 DVT와 PE의 위험과 결과에 대한 인식이 높아짐에 따라 IVC 필터에 대한 수요가 증가하고 있습니다.
각국 규제 당국은 정맥혈전색전증 예방에 초점을 맞춘 인식 제고 활동, 캠페인, 교육 이니셔티브 추진을 통해 IVC 필터 도입을 장려하고 있습니다. 또한, 진단 능력의 급속한 발전으로 DVT 및 PE 사례를 보다 정확하고 신속하게 감지할 수 있게 되어 환자 예후가 개선되고 있습니다. 또한, 조기 진단을 통해 의료진은 하대정맥 필터를 삽입하는 것이 도움이 될 수 있는 환자를 식별할 수 있습니다. 폐색전증을 예방하기 위한 신뢰할 수 있고 효과적인 솔루션으로 하대정맥 필터의 사용이 증가하면서 시장 성장에 기여하고 있습니다.
IVC 필터 기술의 발전
다양한 제조업체들이 제품의 안전성과 유효성을 향상시키기 위해 IVC 필터 기술의 급속한 발전을 위해 노력하고 있습니다. 또한, 폐색전증 위험이 사라진 후 제거 가능한 회수형 IVC 필터의 도입이 증가하고 있습니다. 이러한 회수형 필터는 의료진에게 환자를 효과적으로 관리할 수 있는 유연성과 선택권을 제공함으로써 시장 전망을 밝게 하고 있습니다. 또한, 필터의 설계 및 소재에 대한 다양한 기술적 진보를 통해 생체적합성을 향상시키고 부작용 및 장기적인 합병증 위험을 감소시키고 있습니다. 이와 더불어, IVC 필터의 효능이 높아지면서 적절한 사례에서 도입률이 증가하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 하대정맥 필터 시장
제6장 시장 분석 : 제품별
제7장 시장 분석 : 소재별
제8장 시장 분석 : 용도별
제9장 시장 분석 : 최종 사용자별
제10장 시장 분석 : 지역별
제11장 촉진, 억제 및 기회
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
JHS 26.05.18The global inferior vena cava (IVC) filter market size reached USD 822.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,503.8 Million by 2034, exhibiting a growth rate (CAGR) of 6.72% during 2026-2034. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
INFERIOR VENA CAVA (IVC) FILTER MARKET TRENDS/DRIVERS:
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
INFERIOR VENA CAVA (IVC) FILTER INDUSTRY SEGMENTATION:
Breakup by Product:
- Retrievable IVC Filter
- Permanent IVC Filter
Retrievable IVC filter represents the largest market segment
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Breakup by Material:
- Non-Ferromagnetic Material
- Ferromagnetic Materials
Non-ferromagnetic material accounts for the majority of the market share
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Breakup by Application:
- Treatment Venous Thromboembolism (VTE)
- Prevent Pulmonary Embolism (PE)
- Others
Treatment venous thromboembolism (VTE) holds the biggest market share
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Hospitals dominate the market share
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
COMPETITIVE LANDSCAPE:
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- ALN Implants Chirurgicaux
- Argon Medical Devices Inc.
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Braile Biomedica
- Cook Group Incorporated
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global inferior vena cava (IVC) filter market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global inferior vena cava (IVC) filter market?
- What is the impact of each driver, restraint, and opportunity on the global inferior vena cava (IVC) filter market?
- What are the key regional markets?
- Which countries represent the most attractive inferior vena cava (IVC) filter market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the inferior vena cava (IVC) filter market?
- What is the breakup of the market based on the material?
- Which is the most attractive material in the inferior vena cava (IVC) filter market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the inferior vena cava (IVC) filter market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the inferior vena cava (IVC) filter market?
- What is the competitive structure of the global inferior vena cava (IVC) filter market?
- Who are the key players/companies in the global inferior vena cava (IVC) filter market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Inferior Vena Cava (IVC) Filter Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Retrievable IVC Filter
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Permanent IVC Filter
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Material
- 7.1 Non-Ferromagnetic Material
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Ferromagnetic Materials
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Treatment Venous Thromboembolism (VTE)
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Prevent Pulmonary Embolism (PE)
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgical Centers (ASCs)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 ALN Implants Chirurgicaux
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Argon Medical Devices Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 B. Braun Melsungen AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Becton Dickinson and Company
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Braile Biomedica
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Cook Group Incorporated
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.1 ALN Implants Chirurgicaux
